Early sepsis detection: molecular immune markers show limited impact in screening tools

Researchers evaluated the additional predictive value of molecular immune markers with the Predict Sepsis screening tools developed previously by the same research team.

Pilates lowers blood pressure in hypertensive patients, study finds

Pilates training programs are deemed safe and effective for managing blood pressure in hypertensive patients, offering a viable rehabilitation option alongside traditional treatments.

February 18, 2024

FDA OKs Once-Daily Injection for Hypoparathyroidism

After rejecting it a year ago, the FDA approved once-daily palopegteriparatide (Yorvipath) for adults with hypoparathyroidism, drugmaker Ascendis Pharma announced on Monday. Injectable palopegteriparatide is

August 13, 2024

Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment

Up to 19% of prevalent dementia cases may be attributable to impaired vision, a cross-sectional analysis suggested. Contrast sensitivity impairment showed the strongest relationship, followed

September 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.